CVR derivative liability noncurrent.

No definition available.

Name:	gyre_CVRDerivativeLiabilityNoncurrent
Namespace Prefix:	gyre_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Commitments and contingencies disclosure.

+ References

No definition available.

+ Details

Name:	gyre_CommitmentsAndContingenciesDisclosureLineItems
Namespace Prefix:	gyre_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Committed to allocate.

+ References

No definition available.

+ Details

Name:	gyre_CommittedToAllocate
Namespace Prefix:	gyre_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Contingent value rights derivative liability non current.

+ References

No definition available.

+ Details

Name:	gyre_ContingentValueRightsDerivativeLiabilityNonCurrent
Namespace Prefix:	gyre_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Contributions closing payable amount.

+ References

No definition available.

+ Details

Name:	gyre_ContributionsClosingPayableAmount
Namespace Prefix:	gyre_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Distribution from asset sale proceeds.

+ References

No definition available.

+ Details

Name:	gyre_DistributionFromAssetSaleProceeds
Namespace Prefix:	gyre_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Excess amount retained from net proceeds related to disposition of assets.

+ References

No definition available.

+ Details

Name:	gyre_ExcessAmountRetainedFromNetProceedsRelatedToDispositionOfAssets
Namespace Prefix:	gyre_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Obligation to pay in exchange for the intellectual property rights.

+ References

No definition available.

+ Details

Name:	gyre_ObligationToPayInExchangeForTheIntellectualPropertyRights
Namespace Prefix:	gyre_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Percentage of amount received on agreement.

+ References

No definition available.

+ Details

Name:	gyre_PercentageOfAmountReceivedOnAgreement
Namespace Prefix:	gyre_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of excess cash on dispositions net.

+ References

No definition available.

+ Details

Name:	gyre_PercentageOfExcessCashOnDispositionsNet
Namespace Prefix:	gyre_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of excess preapproved costs.

+ References

No definition available.

+ Details

Name:	gyre_PercentageOfExcessPreapprovedCosts
Namespace Prefix:	gyre_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_LitigationReserve
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-13

+ Details

Name:	us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_CapitalAdditionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=gyre_ContingentValueRightsAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=gyre_VertexAssetPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=gyre_FThreeFiveOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=gyre_BeijingContinentPharmaceuticalsCoLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=gyre_SubmissionOfTheNewDrugApplicationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=gyre_NDAPassesTheNMPAsReviewAndInspectionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=gyre_NMPAsApprovalOfTheNDAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands		1 Months Ended		12 Months Ended
	Oct. 30, 2023	Apr. 30, 2023	Feb. 28, 2023	Dec. 31, 2023	Dec. 31, 2022
Commitments And Contingencies Disclosure [Line Items]
CVR derivative liability				$ 4,722
Purchase of property and equipment				8,517	$ 4,985
Property and Equipment
Commitments And Contingencies Disclosure [Line Items]
Purchase of property and equipment				2,800
Research and Development
Commitments And Contingencies Disclosure [Line Items]
Committed to allocate				$ 12,700
Contingent Value Rights Agreement
Commitments And Contingencies Disclosure [Line Items]
Percentage of excess cash on dispositions net				100.00%
Excess amount retained from net proceeds related to disposition of assets				$ 1,000
Percentage of excess preapproved costs				100.00%
Distribution to CVR holders from asset sale proceeds			$ 200
Long-term CVR derivative liability			$ 4,500
CVR derivative liability				$ 4,700
Contributions closing payable amount	$ 1,100
Litigation expenses		$ 400
Litigation settlement liability	$ 400
Vertex Asset Purchase Agreement \| Contingent Value Rights Agreement
Commitments And Contingencies Disclosure [Line Items]
Percentage of amount received on agreement				100.00%
F351 \| BC \| Submission of the New Drug Application
Commitments And Contingencies Disclosure [Line Items]
Obligation to pay in exchange for the intellectual property rights				$ 4,800
F351 \| BC \| NDA Passes the NMPA's Review and Inspection
Commitments And Contingencies Disclosure [Line Items]
Obligation to pay in exchange for the intellectual property rights				1,200
F351 \| BC \| NMPA's Approval of the NDA
Commitments And Contingencies Disclosure [Line Items]
Obligation to pay in exchange for the intellectual property rights				$ 7,200